21252141

Source:http://linkedlifedata.com/resource/pubmed/id/21252141

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0021201, umls-concept:C0030705, umls-concept:C0041296, umls-concept:C0242339, umls-concept:C1963724
pubmed:issue	4
pubmed:dateCreated	2011-1-24
pubmed:abstractText	Our aim was to study the incidence and pattern of dyslipidemia among human immunodeficiency virus (HIV)-infected patients with tuberculosis (TB) who received once-daily antiretroviral therapy (ART).
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/1P30AI42353-12, http://linkedlifedata.com/resource/pubmed/grant/2D43TW000237-17, http://linkedlifedata.com/resource/pubmed/grant/UL1 RR025752
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/21252141-11740191, http://linkedlifedata.com/resource/pubmed/commentcorrection/21252141-12485966, http://linkedlifedata.com/resource/pubmed/commentcorrection/21252141-12821825, http://linkedlifedata.com/resource/pubmed/commentcorrection/21252141-14999610, http://linkedlifedata.com/resource/pubmed/commentcorrection/21252141-15526045, http://linkedlifedata.com/resource/pubmed/commentcorrection/21252141-15721096, http://linkedlifedata.com/resource/pubmed/commentcorrection/21252141-15807717, http://linkedlifedata.com/resource/pubmed/commentcorrection/21252141-15905737, http://linkedlifedata.com/resource/pubmed/commentcorrection/21252141-16268821, http://linkedlifedata.com/resource/pubmed/commentcorrection/21252141-16306305, http://linkedlifedata.com/resource/pubmed/commentcorrection/21252141-17460470, http://linkedlifedata.com/resource/pubmed/commentcorrection/21252141-18348170, http://linkedlifedata.com/resource/pubmed/commentcorrection/21252141-18398971
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9203213
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Anti-HIV Agents, http://linkedlifedata.com/resource/pubmed/chemical/Antitubercular Agents, http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, http://linkedlifedata.com/resource/pubmed/chemical/Lipoproteins, http://linkedlifedata.com/resource/pubmed/chemical/Reverse Transcriptase Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Triglycerides
pubmed:status	MEDLINE
pubmed:month	Feb
pubmed:issn	1537-6591
pubmed:author	pubmed-author:MenonPradeep APA, pubmed-author:NarendranGopalanG, pubmed-author:PadmapriyadarsiniChandrasekaranC, pubmed-author:RamachandranGeethaG, pubmed-author:Ramesh KumarSS, pubmed-author:SubramanyanSudhaS, pubmed-author:SwaminathanSoumyaS, pubmed-author:TerrinNormaN, pubmed-author:VenkatesanPerumalP, pubmed-author:WankeChristineC
pubmed:issnType	Electronic
pubmed:day	15
pubmed:volume	52
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	540-6
pubmed:dateRevised	2011-7-26
pubmed:meshHeading	pubmed-meshheading:21252141-Adult, pubmed-meshheading:21252141-Anti-HIV Agents, pubmed-meshheading:21252141-Antiretroviral Therapy, Highly Active, pubmed-meshheading:21252141-Antitubercular Agents, pubmed-meshheading:21252141-Cholesterol, pubmed-meshheading:21252141-Dyslipidemias, pubmed-meshheading:21252141-Female, pubmed-meshheading:21252141-HIV Infections, pubmed-meshheading:21252141-Humans, pubmed-meshheading:21252141-Incidence, pubmed-meshheading:21252141-India, pubmed-meshheading:21252141-Lipoproteins, pubmed-meshheading:21252141-Male, pubmed-meshheading:21252141-Reverse Transcriptase Inhibitors, pubmed-meshheading:21252141-Triglycerides, pubmed-meshheading:21252141-Tuberculosis
pubmed:year	2011
pubmed:articleTitle	Dyslipidemia among HIV-infected Patients with tuberculosis taking once-daily nonnucleoside reverse-transcriptase inhibitor-based antiretroviral therapy in India.
pubmed:affiliation	Tuberculosis Research Centre, Chennai, India.
pubmed:publicationType	Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural